Area of research
Pulmonary and Respiratory Medicine · Molecular Biology
Research interest
Research interests include Prostate Cancer Treatment and Research, Epigenetics and DNA Methylation, Cancer, Lipids, and Metabolism, and Cancer-related molecular mechanisms research.
Defining CDK12 as a tumor suppressor and therapeutic target in mouse models of tubo-ovarian high-grade serous carcinoma
NSD2 is a requisite subunit of the AR/FOXA1 neo-enhanceosome in promoting prostate tumorigenesis
CDK12 loss drives prostate cancer progression, transcription-replication conflicts, and synthetic lethality with paralog CDK13
Author Correction: Targeting SWI/SNF ATPases in enhancer-addicted prostate cancer
Distinct structural classes of activating FOXA1 alterations in advanced prostate cancer
Polycomb group proteins EZH2 and EED directly regulate androgen receptor in advanced prostate cancer
Epigenetic Reprogramming with Antisense Oligonucleotides Enhances the Effectiveness of Androgen Receptor Inhibition in Castration-Resistant Prostate Cancer
Development of Peptidomimetic Inhibitors of the ERG Gene Fusion Product in Prostate Cancer
Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer
The central role of EED in the orchestration of polycomb group complexes
The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI/SNF complex